Powder: -20°C for 3 years | In solvent: -80°C for 1 year
SN 6 (SN6) 是选择性NCX 抑制剂,可抑制 NCX1、NCX2 和 NCX3 对45Ca2+的吸收,IC50值分别为 2.9、16 和 8.6 μM。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 295 | 现货 | ||
2 mg | ¥ 423 | 现货 | ||
5 mg | ¥ 695 | 现货 | ||
10 mg | ¥ 1,070 | 现货 | ||
25 mg | ¥ 2,150 | 现货 | ||
50 mg | ¥ 3,220 | 现货 | ||
100 mg | ¥ 4,630 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 765 | 现货 |
产品描述 | SN 6 (SN6) is a selective Na+/Ca2+ exchanger (NCX) inhibitor (IC50s of NCX1: 2.9 μM , NCX2: 16 μM ,NCX3: 8.6 μM) |
靶点活性 | NCX3:8.6 μM, NCX1:2.9μM , NCX2:16μM |
体外活性 | SN-6 [2-[4-(4-nitrobenzyloxy)benzyl]thiazolidine-4-carboxylic acid ethyl ester], a newly synthesized and selective Na(+)/Ca(2+) exchange (NCX) inhibitor. SN-6 (0.3-30 microM) inhibited preferentially intracellular Na(+)-dependent (45)Ca(2+) uptake (i.e., the reverse mode) compared with extracellular Na(+)-dependent (45)Ca(2+) efflux (i.e., the forward mode) in NCX1-transfected fibroblasts. SN-6 was 3- to 5-fold more inhibitory to (45)Ca(2+) uptake in NCX1 (IC(50) = 2.9 microM) than to that in NCX2 or NCX3. SN-6 at lower doses (IC(50) = 0.63 microM) potently protected against hypoxia/reoxygenation-induced cell damage in renal tubular cells overexpressing NCX1, suggesting that this drug predominantly works under hypoxic/ischemic conditions. These properties of SN-6, which may be derived from its interaction with the XIP region, are advantageous to developing it as a new anti-ischemic drug. |
细胞实验 | Confluent transfectants in 24-well dishes were loaded with Na+ by incubation at 37°C for 40 min in 0.5 ml of balanced salt solution (BSS) (10 mM HEPES/Tris, pH 7.4, 146 mM NaCl, 4 mM KCl, 2 mM MgCl2, 0.1 mM CaCl2, 10 mM glucose, and 0.1% bovine serum albumin) containing 1 mM ouabain and 10 mM monensin. 45Ca2+ uptake was then initiated by switching the medium to Na+ -free BSS (replacing NaCl with equimolar choline chloride) or to normal BSS, both of which contained 0.1 mM 45CaCl2 (370 kBq/ml) and 1 mM ouabain. After a 30-s incubation, 45Ca2+ uptake was terminated by washing cells four times with an ice-cold solution containing 10 mM HEPES/Tris, pH 7.4, 120 mM choline chloride,and 10 mM LaCl3. Cells were then solubilized with 0.1 N NaOH, and aliquots were taken for determination of radioactivity and protein. When present, SN-6 and KB-R7943 were included in the medium 15 min before the start of 45Ca2+ uptake |
别名 | SN6 |
分子量 | 402.46 |
分子式 | C20H22N2O5S |
CAS No. | 415697-08-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: Insoluble
DMSO: 62.5 mg/mL (155.29 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.4847 mL | 12.4236 mL | 24.8472 mL | 62.118 mL |
5 mM | 0.4969 mL | 2.4847 mL | 4.9694 mL | 12.4236 mL | |
10 mM | 0.2485 mL | 1.2424 mL | 2.4847 mL | 6.2118 mL | |
20 mM | 0.1242 mL | 0.6212 mL | 1.2424 mL | 3.1059 mL | |
50 mM | 0.0497 mL | 0.2485 mL | 0.4969 mL | 1.2424 mL | |
100 mM | 0.0248 mL | 0.1242 mL | 0.2485 mL | 0.6212 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
SN 6 415697-08-4 Membrane transporter/Ion channel Metabolism Calcium Channel Na+/Ca2+ Exchanger inhibit SN6 SN-6 Inhibitor inhibitor